Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in
4.9 (398) · € 27.99 · En Stock
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study - The Lancet Microbe
Emergence of the SARS-CoV-2 Omicron Variant: Current Treatments and Vaccines for COVID-19
Full article: Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Farmacovigilancia de vacunas para COVID-19 - Sinovac
Measuring vaccine effectiveness from limited public health datasets: Framework and estimates from India's second COVID wave
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University - ScienceDirect
COVID-19 mRNA vaccines: Platforms and current developments: Molecular Therapy
Full article: Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - ScienceDirect
The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021 - Katz - 2023 - Influenza and Other Respiratory Viruses - Wiley Online Library
Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile
